Barclays analyst Andrew Mok CFA maintained a Sell rating on Agilon Health (AGL – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at $4.98.
Mok CFA covers the Healthcare sector, focusing on stocks such as DaVita, Encompass Health, and Acadia Healthcare. According to TipRanks, Mok CFA has an average return of -4.1% and a 48.51% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Agilon Health with a $7.29 average price target.
The company has a one-year high of $26.75 and a one-year low of $4.41. Currently, Agilon Health has an average volume of 4.65M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Agilon Health (AGL) Company Description:
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
